Status:
WITHDRAWN
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Lead Sponsor:
AstraZeneca
Conditions:
Head and Neck Cancer
Carcinoma, Squamous Cell
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.
Eligibility Criteria
Inclusion
- Histologically Confirmed locally advanced Squamous Cell Carcinoma of Head and neck
- At least one measurable tumour lesion
Exclusion
- No previous treatment such as chemotherapy, radiotherapy and/or surgery for Carcinoma Head and Neck
- No other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ
- Any evidence of severe or uncontrolled systemic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease)
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00233636
Start Date
July 1 2003
Last Update
January 27 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aviano, Italy
2
Research Site
Azienda, Italy
3
Research Site
Milan, Italy
4
Research Site
Napoli, Italy